drugset / Trial / NCT02321527
Feasibility of Ultrasound Microbubble Contrast-Enhanced (CEUS) Sentinel Lymph Node Imaging With Guided Biopsy in Breast Cancer Patients
NaSingle-groupOpen-labelScreening
Summary
The goal of this clinical research is to learn if an ultrasound contrast agent called OPTISON (perflutren protein type A) is effective in finding sentinel lymph nodes before surgery. Contrast agents can help make ultrasound images more accurate. The sentinel lymph node is the first node that may be the target of cancer cells that spread from the tumor.
Timeline
- Start
- 2015-07
- Primary completion
- 2016-05
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | perflutren protein type A | Diagnostic / imaging agent | 0.2 ml | Subcutaneous |
| Subject | perflutren protein type A | Diagnostic / imaging agent | 0.5 ml | Subcutaneous |